ecancermedicalscience editor's choice for November 2014
ecancermedicalscience editor's choice for November 2014
Biomarker for PARP inhibitor responsiveness in ovarian cancer patients
New drug, ASP8273, shows response in Japanese patients with treatment-resistant non-small cell lung cancer
New emerging treatments and challenges in MCL, MM and CLL: Expert panel discussion
Interventional oncology: The next oncological discipline
Cancer genomics and pancreatic cancer
Fly models and genome sequencing
New radiotherapy techniques target lung cancer with less toxicity
Comment: NCRI 2014 conference – Highlights and the future
Malignant brain tumours and the role of genetically engineered mice models
Targeting PI3K in female cancers
The role of NCRI in promoting collaborative research initiatives